United States · 
Who invested in Volastra Therapeutics?
Volastra Therapeutics's investors include B Capital, Polaris Partners, ARCH Venture Partners, Eli Lilly and Catalio Capital Management.
United States · Series A startup
Who invested in Volastra Therapeutics
Funding summaryUpdated 26 Oct 2026
$30Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $30MSept 2025
- Investors
- 5
The rounds
- Sept 2025Series A$30M
Source recordedSEC filing: $30M sold, first sale Sept 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Volastra Therapeutics
How much has Volastra Therapeutics raised?
Volastra Therapeutics has raised $30M across 1 round since 2025.
When did Volastra Therapeutics last raise?
Volastra Therapeutics's most recent round was a Series A of $30M in Sept 2025.
What was Volastra Therapeutics's biggest round?
Its most recent round, $30M in Sept 2025, is also its largest on record.
Who backed Volastra Therapeutics first?
Volastra Therapeutics's first round on record, in Sept 2025, was backed by B Capital, Polaris Partners and ARCH Venture Partners and 2 others.
What stage is Volastra Therapeutics at?
Volastra Therapeutics's latest named round is a Series A, in Sept 2025.
Where is Volastra Therapeutics based?
Volastra Therapeutics is based in the United States.
Companies like Volastra Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.